Please try another search
SUSMED,Inc. develops and sells therapeutic applications in Japan. It develops smartphone applications for the treatment of patients with insomnia, breast cancer, kidney disease, etc. The company also develops and sells a collaborative development platform for therapeutic apps; clinical trial systems; and medical equipment. In addition, it offers medical data analysis and consulting services, as well as collects and distributes medical information. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
Name | Age | Since | Title |
---|---|---|---|
Kenta Nagao | 65 | 2020 | Audit & Supervisory Board Member |
Takayuki Kohara | 46 | 2021 | Director of Administration & Director |
Yasuhiro Yamada | - | 2022 | Independent Outside Director |
Kuniaki Kaga | 72 | 2021 | Independent Outside Director |
Tomomitsu Motohashi | 40 | 2019 | CTO & Director |
Makiko Yamamoto | 52 | 2021 | Audit & Supervisory Board Member |
Yuko Akishima | 65 | 2019 | Chairman of Audit & Supervisory Board |
Taro Ueno | 43 | - | Chairman, CEO & President |
Yusuke Yajima | 39 | 2021 | COO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review